Book contents
- How to Prepare the Egg and Embryo to Maximize IVF Success
- How to Prepare the Egg and Embryo to Maximize IVF Success
- Copyright page
- Contents
- Contributors
- Section 1 Oocyte Recruitment
- Section 2 Stimulation for IVF
- Section 3 Supplements to Improve Oocytes
- Chapter 11 The Use of DHEA to Improve Oocyte Quality
- Chapter 12 Implications of Polycystic Ovary Syndrome on Oocyte Quality
- Chapter 13 The Use of Melatonin to Improve Oocyte Development
- Chapter 14 The Use of LH Supplements to Improve the Response to Ovarian Stimulation
- Chapter 15 Growth Hormone as an Adjunct to Controlled Ovarian Hyperstimulation for IVF
- Chapter 16 Mitochondrial Transfer Technology for Improving Older Eggs
- Section 4 Oocyte and Embryo Culture
- Section 5 Embryo Selection and Transfer
- Index
- References
Chapter 11 - The Use of DHEA to Improve Oocyte Quality
from Section 3 - Supplements to Improve Oocytes
Published online by Cambridge University Press: 04 January 2019
By
Book contents
- How to Prepare the Egg and Embryo to Maximize IVF Success
- How to Prepare the Egg and Embryo to Maximize IVF Success
- Copyright page
- Contents
- Contributors
- Section 1 Oocyte Recruitment
- Section 2 Stimulation for IVF
- Section 3 Supplements to Improve Oocytes
- Chapter 11 The Use of DHEA to Improve Oocyte Quality
- Chapter 12 Implications of Polycystic Ovary Syndrome on Oocyte Quality
- Chapter 13 The Use of Melatonin to Improve Oocyte Development
- Chapter 14 The Use of LH Supplements to Improve the Response to Ovarian Stimulation
- Chapter 15 Growth Hormone as an Adjunct to Controlled Ovarian Hyperstimulation for IVF
- Chapter 16 Mitochondrial Transfer Technology for Improving Older Eggs
- Section 4 Oocyte and Embryo Culture
- Section 5 Embryo Selection and Transfer
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- How to Prepare the Egg and Embryo to Maximize IVF Success , pp. 141 - 149Publisher: Cambridge University PressPrint publication year: 2019
References
Gleicher, N, Kushnir, VA, Albertini, DF, Barad, DH. (2016). Improvements in IVF in women of advanced age. J Endocrinol., 230(1),F1–6. Epub May 6.CrossRefGoogle ScholarPubMed
Ferraretti, E, La Marca, A, Fauser, B et al. on behalf of the ESHRE working group on Poor Ovarian Response Definition. (2011). ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction, 26(7), 1616–1624.Google Scholar
Rittenberg, V, Seshadri, S, Sunkara, SK et al. (2011). Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis. Reprod Biomed Online, 23(4), 421.CrossRefGoogle ScholarPubMed
Augood, C, Duckitt, K, Templeton, AA. (1998). Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod., 13(6), 1532.CrossRefGoogle ScholarPubMed
Meldrum, DR, Casper, RF, Diez-Juan, A et al. (2016). Aging and the environment affect gamete and embryo potential: can we intervene? Fertil Steril., 105(3), 548–559.CrossRefGoogle ScholarPubMed
Bentov, Y, Hannam, T, Jurisicova, A, Esfandiari, N, Casper, RF. (2014). Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clin Med Insights Reprod Health. 8, 31–36.Google Scholar
Arlt, W, Justl, HG, Callies, F et al. (1998). Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab., 83, 1928–1934.CrossRefGoogle ScholarPubMed
Franasiak, JM, Thomas, S, Ng, S et al. (2016). Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA-S serum levels and progesterone assay interference that may impact clinical management in IVF. Journal of Assisted Reproductive Genetics, 33(3), 387–391.Google Scholar
Davison, SL, Bell, R, Donath, S, Montalto, JG, Davis, SR. (2005). Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab., 90, 3847–3853.Google Scholar
Wierman, ME, Arlt, W, Basson, R et al. (2014). Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 99(10), 3489–3510.Google Scholar
Elraiyah, T, Sonbol, MB, Wang, Z et al. (2014). The benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 99, 3536–3542.Google Scholar
Casson, PR, Lindsay, MS, Pisarska, MD, Carson, SA, Buster, JE. (2000). Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod. 15, 2129–2132.Google Scholar
Vendola, K, Zhou, J, Wang, J et al. (1999). Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod., 61, 353–357.CrossRefGoogle ScholarPubMed
Vendola, KA, Zhou, J, Adesanya, OO, Weil, SJ, Bondy, CA. (1998) Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest., 101, 2622–2629.CrossRefGoogle ScholarPubMed
Nielsen, ME, Rasmussen, IA, Kristensen, SG et al. (2011). In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Molecular Human Reproduction, 17(1), 63–70.Google Scholar
Haning, RV Jr, Hackett, RJ, Flood, CA et al. (1993). Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. Clin Endocrinol Metab., 76, 1301–1307.Google Scholar
Barad, D, Gleicher, N. (2006). Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Human Reproduction, 21, 2845–2849.Google Scholar
Nagels, HE, Rishworth, JR, Siristatidis, CS, Kroon, B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews, 2015, Issue 11. Art. No.: CD009749. DOI: 10.1002/14651858.CD009749.pub2.Google Scholar
Yeung, T, Chai, J, Li, R et al. (2016). A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. British Journal of Obstetrics and Gynaecology. 123(7), 1097–1105.Google Scholar
Kotb, MM, Hassan, AM, AwadAllah, AM. (2016). Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial. European Journal of Obstetrics, Gynecology and Reproductive Biology, 200, 11–15.Google Scholar
Zhang, M, Niu, W, Wang, Y et al. (2016). Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis. J Assist Reprod Genet., 33(8), 981–991.CrossRefGoogle ScholarPubMed
Triantafyllidou, O, Sigalos, G, Vlahos, N. (2016). Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders. Hum Fertil (Camb). 7, 1–8. [Epub ahead of print]Google Scholar
Qin, JC, Fan, L, Qin, AP. (2016).The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: Evidence from a meta-analysis. J Gynecol Obstet Biol Reprod (Paris). 2016 May 19. p ii: S0368-2315(16)00003-X. doi: 10.Google Scholar
Nardo, L, El-Toukhy, T, Stewart, J, Balen, AH, Potdar, N. (2015). British fertility society policy and practice committee: adjuvants in IVF: evidence for good clinical practice. Human Fertility, 18(1), 2–15, DOI: 10.3109/14647273.2015.985454CrossRefGoogle Scholar